X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs JUBILANT LIFE SCIENCES - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS JUBILANT LIFE SCIENCES IPCA LABS/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 41.9 27.4 152.7% View Chart
P/BV x 3.2 5.6 57.0% View Chart
Dividend Yield % 0.2 0.3 49.5%  

Financials

 IPCA LABS   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    IPCA LABS
Mar-17
JUBILANT LIFE SCIENCES
Mar-14
IPCA LABS/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs643187 344.2%   
Low Rs50365 772.4%   
Sales per share (Unadj.) Rs254.4364.3 69.8%  
Earnings per share (Unadj.) Rs16.16.8 234.7%  
Cash flow per share (Unadj.) Rs29.824.5 121.5%  
Dividends per share (Unadj.) Rs1.003.00 33.3%  
Dividend yield (eoy) %0.22.4 7.3%  
Book value per share (Unadj.) Rs194.6164.9 118.0%  
Shares outstanding (eoy) m126.20159.28 79.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.30.3 651.4%   
Avg P/E ratio x35.718.4 193.8%  
P/CF ratio (eoy) x19.25.1 374.3%  
Price / Book Value ratio x2.90.8 385.5%  
Dividend payout %6.243.8 14.2%   
Avg Mkt Cap Rs m72,30020,061 360.4%   
No. of employees `00013.36.2 215.1%   
Total wages/salary Rs m6,96011,052 63.0%   
Avg. sales/employee Rs Th2,413.59,383.0 25.7%   
Avg. wages/employee Rs Th523.21,786.9 29.3%   
Avg. net profit/employee Rs Th152.4176.3 86.5%   
INCOME DATA
Net Sales Rs m32,10658,034 55.3%  
Other income Rs m226191 118.4%   
Total revenues Rs m32,33258,224 55.5%   
Gross profit Rs m4,4485,786 76.9%  
Depreciation Rs m1,7302,812 61.5%   
Interest Rs m2413,237 7.4%   
Profit before tax Rs m2,703-72 -3,749.2%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m675696 97.0%   
Profit after tax Rs m2,0281,090 186.0%  
Gross profit margin %13.910.0 138.9%  
Effective tax rate %25.0-965.9 -2.6%   
Net profit margin %6.31.9 336.2%  
BALANCE SHEET DATA
Current assets Rs m17,34029,280 59.2%   
Current liabilities Rs m9,55938,912 24.6%   
Net working cap to sales %24.2-16.6 -146.0%  
Current ratio x1.80.8 241.1%  
Inventory Days Days10084 118.9%  
Debtors Days Days5751 112.2%  
Net fixed assets Rs m20,77955,712 37.3%   
Share capital Rs m252155 163.4%   
"Free" reserves Rs m24,49920,968 116.8%   
Net worth Rs m24,55326,265 93.5%   
Long term debt Rs m3,51717,169 20.5%   
Total assets Rs m39,59588,606 44.7%  
Interest coverage x12.21.0 1,250.4%   
Debt to equity ratio x0.10.7 21.9%  
Sales to assets ratio x0.80.7 123.8%   
Return on assets %5.74.9 117.3%  
Return on equity %8.34.2 199.0%  
Return on capital %10.511.6 90.7%  
Exports to sales %48.637.8 128.7%   
Imports to sales %14.216.5 86.4%   
Exports (fob) Rs m15,61721,933 71.2%   
Imports (cif) Rs m4,5719,567 47.8%   
Fx inflow Rs m15,61722,004 71.0%   
Fx outflow Rs m5,82811,749 49.6%   
Net fx Rs m9,79010,255 95.5%   
CASH FLOW
From Operations Rs m2,7648,026 34.4%  
From Investments Rs m-1,432-1,744 82.1%  
From Financial Activity Rs m-1,591-4,447 35.8%  
Net Cashflow Rs m-2591,834 -14.1%  

Share Holding

Indian Promoters % 45.9 45.6 100.7%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 11.4 8.7 131.0%  
FIIs % 25.3 21.2 119.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 21.1 82.5%  
Shareholders   36,892 23,815 154.9%  
Pledged promoter(s) holding % 2.1 15.9 13.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Feb 16, 2018 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS